Raloxifene

CHEMBL81 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

473.6 g/mol

LogP

6.1

Phase

4

A selective estrogen receptor modulator used to prevent and treat osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in women at high risk. It mimics some of estrogen's beneficial effects on bone density without stimulating breast or uterine tissue.

Peso Molecular

473,6000 g/mol

LogP

6,10

TPSA

98,20 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Endometriosis Benign Prostatic Hyperplasia Cardiovascular Disease Rheumatoid Arthritis Osteoporosis Schizophrenia Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12

InChI

InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2

Molecular Formula

C28H27NO4S

HBD / HBA

2 / 6

Ligações Rotacionáveis

7

Átomos Pesados

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A selective estrogen receptor modulator used to prevent and treat osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in women at high risk. It mimics some of estrogen's beneficial effects on bone density without stimulating breast or uterine tissue.

Yes, Raloxifene is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL81. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5035. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Raloxifene no PillFYI

Estrutura

Dados Rápidos

Fórmula: C28H27NO4S
Sinônimos: 2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.